Praxis Investment Management Inc. Sells 1,762 Shares of Humana Inc. $HUM

Praxis Investment Management Inc. lessened its position in Humana Inc. (NYSE:HUMFree Report) by 52.2% in the first quarter, HoldingsChannel reports. The fund owned 1,613 shares of the insurance provider’s stock after selling 1,762 shares during the quarter. Praxis Investment Management Inc.’s holdings in Humana were worth $280,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HUM. Revolve Wealth Partners LLC bought a new stake in Humana during the 4th quarter valued at $202,000. Woodline Partners LP grew its holdings in shares of Humana by 460.0% during the first quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock valued at $2,697,000 after buying an additional 8,372 shares during the last quarter. Sivia Capital Partners LLC grew its holdings in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after buying an additional 452 shares during the last quarter. Cresset Asset Management LLC increased its position in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock worth $581,000 after acquiring an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd raised its holdings in shares of Humana by 58.5% in the 2nd quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock worth $582,000 after acquiring an additional 879 shares during the last quarter. Institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

HUM has been the subject of a number of analyst reports. The Goldman Sachs Group lifted their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Deutsche Bank Aktiengesellschaft lowered Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Monday, June 29th. Mizuho upped their price target on Humana from $335.00 to $390.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. Finally, Wells Fargo & Company cut Humana from a “cautious” rating to a “reduce” rating in a research note on Wednesday, May 20th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $296.39.

Read Our Latest Stock Analysis on HUM

Humana Stock Performance

Shares of HUM opened at $394.39 on Wednesday. The firm has a market cap of $47.35 billion, a PE ratio of 42.18, a PEG ratio of 2.24 and a beta of 0.71. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $415.00. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. The stock’s fifty day moving average price is $329.02 and its two-hundred day moving average price is $252.29.

Humana (NYSE:HUMGet Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The business had revenue of $39.65 billion for the quarter, compared to analysts’ expectations of $39.37 billion. During the same quarter in the prior year, the firm posted $11.58 EPS. The firm’s quarterly revenue was up 23.5% on a year-over-year basis. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities research analysts forecast that Humana Inc. will post 9.03 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, June 26th. This represents a $3.54 annualized dividend and a yield of 0.9%. Humana’s dividend payout ratio is currently 37.86%.

Humana Company Profile

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

See Also

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUMFree Report).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.